Soni Medicare [SML] vs Shalby [SHALBY] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Soni Medicare Ltd. wins in 8 metrics, Shalby Ltd. wins in 10 metrics, with 0 ties. Shalby Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Soni Medicare Ltd. | Shalby Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 115.75 | 207.28 | Soni Medicare Ltd. |
| Price-to-Book Ratio | 340.87 | 1.75 | Shalby Ltd. |
| Debt-to-Equity Ratio | 12,636.41 | 53.32 | Shalby Ltd. |
| PEG Ratio | 0.16 | -1.45 | Soni Medicare Ltd. |
| EV/EBITDA | -47.04 | 16.45 | Shalby Ltd. |
| Profit Margin (TTM) | -7.45% | 0.72% | Shalby Ltd. |
| Operating Margin (TTM) | -13.97% | 4.65% | Shalby Ltd. |
| EBITDA Margin (TTM) | N/A | 4.65% | N/A |
| Return on Equity | -14.35% | 0.63% | Shalby Ltd. |
| Return on Assets (TTM) | -0.84% | 0.37% | Shalby Ltd. |
| Free Cash Flow (TTM) | $8.11M | $-757.89M | Soni Medicare Ltd. |
| Dividend Yield | N/A | 0.65% | N/A |
| 1-Year Return | 22.36% | -9.97% | Soni Medicare Ltd. |
| Price-to-Sales Ratio (TTM) | 1.12 | 1.55 | Soni Medicare Ltd. |
| Enterprise Value | $396.03M | $22.59B | Shalby Ltd. |
| EV/Revenue Ratio | 1.48 | 2.02 | Soni Medicare Ltd. |
| Gross Profit Margin (TTM) | 73.93% | 41.11% | Soni Medicare Ltd. |
| Revenue per Share (TTM) | $63 | $101 | Shalby Ltd. |
| Earnings per Share (Diluted) | $-4.68 | $0.78 | Shalby Ltd. |
| Beta (Stock Volatility) | -0.70 | 0.47 | Soni Medicare Ltd. |
Soni Medicare Ltd. vs Shalby Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Soni Medicare Ltd. | 0.00% | 0.00% | 3.96% | 50.39% | -27.51% | -27.51% |
| Shalby Ltd. | -0.36% | 1.67% | 8.38% | 18.13% | -13.81% | -12.87% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Soni Medicare Ltd. | 22.36% | 301.10% | 118.89% | 128.13% | 355.97% | 355.97% |
| Shalby Ltd. | -9.97% | 16.94% | -2.37% | -29.55% | -29.55% | -29.55% |
Performance & Financial Health Analysis: Soni Medicare Ltd. vs Shalby Ltd.
| Metric | SML | SHALBY |
|---|---|---|
| Market Information | ||
| Market Cap | ₹299.48M | ₹16.70B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 12 | 80,346 |
| 90 Day Avg. Volume | 158 | 143,083 |
| Last Close | ₹73.00 | ₹176.21 |
| 52 Week Range | ₹43.82 - ₹114.15 | ₹125.82 - ₹274.70 |
| % from 52W High | -36.05% | -35.85% |
| All-Time High | ₹114.15 (Oct 30, 2025) | ₹339.50 (Jan 22, 2024) |
| % from All-Time High | -36.05% | -48.10% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.27% | -0.01% |
| Quarterly Earnings Growth | -0.29% | -0.01% |
| Financial Health | ||
| Profit Margin (TTM) | -0.07% | 0.01% |
| Operating Margin (TTM) | -0.14% | 0.05% |
| Return on Equity (TTM) | -0.14% | 0.01% |
| Debt to Equity (MRQ) | 12,636.41 | 53.32 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹0.21 | ₹92.31 |
| Cash per Share (MRQ) | ₹3.47 | ₹1.77 |
| Operating Cash Flow (TTM) | ₹-10,735,087 | ₹-417,020,000 |
| Levered Free Cash Flow (TTM) | ₹-1,863,768 | ₹62.22M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.65% |
| Last 12-Month Dividend | N/A | ₹1.20 |
Valuation & Enterprise Metrics Analysis: Soni Medicare Ltd. vs Shalby Ltd.
| Metric | SML (Apr 24, 2026) | SHALBY (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 115.75 | 207.28 |
| Forward P/E | N/A | 17.20 |
| PEG Ratio | 0.16 | -1.45 |
| Price to Sales (TTM) | 1.12 | 1.55 |
| Price to Book (MRQ) | 340.87 | 1.75 |
| Market Capitalization | ||
| Market Capitalization | ₹299.48M | ₹16.70B |
| Enterprise Value | ₹396.03M | ₹22.59B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.48 | 2.02 |
| Enterprise to EBITDA | -47.04 | 16.45 |
| Risk & Other Metrics | ||
| Beta | -0.70 | 0.47 |
| Book Value per Share (MRQ) | ₹0.21 | ₹92.31 |
Financial Statements Comparison: Soni Medicare Ltd. vs Shalby Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SML (2025) | SHALBY (2025) |
|---|---|---|
| Revenue/Sales | 298.38M | 10.81B |
| Cost of Goods Sold | 84.88M | 6.35B |
| COGS % of Revenue | 28.4% | 58.8% |
| Gross Profit | 213.51M | 4.46B |
| Gross Margin | 71.6% | 41.2% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 11.34M | 779.43M |
| Operating Margin | 3.8% | 7.2% |
| EBITDA | 19.65M | 1.51B |
| EBITDA Margin | 6.6% | 14.0% |
| Pre-Tax Income | -2.22M | 557.29M |
| Pre-Tax Income % of Revenue | -0.7% | 5.2% |
| Income Tax | -353,039 | 538.09M |
| Income Tax % of Revenue | -0.1% | 5.0% |
| Net Income (Profit) | -1.86M | 19.20M |
| Profit Margin | -0.6% | 0.2% |
Balance Sheet & Liquidity Metrics
| Metric | SML (2025) | SHALBY (2025) |
|---|---|---|
| Cash & Equivalents | 20.10M | 347.85M |
| Total Current Assets | 137.75M | 6.58B |
| Total Current Assets % of Revenue | 46.2% | 60.9% |
| Total Current Liabilities | 99.90M | 4.55B |
| Total Current Liabilities % of Revenue | 33.5% | 42.1% |
| Long-Term Debt | 94.12M | 1.75B |
| Long-Term Debt % of Revenue | 31.5% | 16.2% |
| Total Shareholders Equity | 12.98M | 9.95B |
| Retained Earnings | -29.75M | 4.44B |
| Retained Earnings % of Revenue | -10.0% | 41.1% |
| Property, Plant & Equipment | 96.87M | 4.36B |
Cash Flow Statement Comparison
| Metric | SML (2025) | SHALBY (2025) |
|---|---|---|
| Operating Cash Flow | -10.74M | -417.02M |
| Operating Cash Flow % of Revenue | -3.6% | -3.9% |
| Capital Expenditures | -6.60M | -700.85M |
| Free Cash Flow | 8.11M | -757.89M |
| FCF Margin | 2.7% | -7.0% |
| Debt Repayment | 0 | -393.05M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SML | SHALBY |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 4.26M | 107.30M |
| Float Shares | 735,707 | 26.51M |
| % Held by Insiders | 81.66% | 76.11% |
| % Held by Institutions | 0.00% | 0.07% |
| % Held by Public | 18.34% | 23.82% |
Dividend Analysis & Yield Comparison: Soni Medicare Ltd. vs Shalby Ltd.
| Metric | SML | SHALBY |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.20 |
| Last 12-Month Dividend Yield | N/A | 0.65% |
| 3-Year Avg Annual Dividend | N/A | ₹1.08 |
| 3-Year Avg Dividend Yield | N/A | 0.55% |
| 3-Year Total Dividends | N/A | ₹3.23 |
| Ex-Dividend Date | N/A | Sep 19, 2024 |